Tadalafil Starting Dose
For erectile dysfunction (ED), start with tadalafil 10 mg taken as needed prior to sexual activity, or 2.5 mg once daily if daily dosing is preferred; for benign prostatic hyperplasia (BPH) or combined ED/BPH, start with 5 mg once daily. 1
Dosing by Indication
Erectile Dysfunction - As Needed Dosing
- Starting dose: 10 mg taken prior to anticipated sexual activity 1
- Can be titrated to 20 mg for increased efficacy or decreased to 5 mg if side effects occur
- Maximum frequency: once per day
- Effective for up to 36 hours after dosing 1
- The 2018 AUA Erectile Dysfunction Guideline strongly recommends dose titration to optimize efficacy 2
Erectile Dysfunction - Daily Dosing
- Starting dose: 2.5 mg once daily 1
- Can be increased to 5 mg daily based on efficacy and tolerability
- Taken at approximately the same time each day, without regard to timing of sexual activity 1
- Daily and as-needed dosing appear to produce similar efficacy levels 2
Benign Prostatic Hyperplasia (BPH)
- Dose: 5 mg once daily 1
- Taken at approximately the same time every day
- When initiating BPH therapy with both tadalafil and finasteride, use 5 mg daily for up to 26 weeks 1
- The 2023 EAU Summary on Male LUTS notes tadalafil 5 mg is the only PDE5 inhibitor licensed for LUTS treatment 3
Combined ED and BPH
- Dose: 5 mg once daily 1
- Taken at approximately the same time each day, without regard to timing of sexual activity
- This single dose addresses both conditions simultaneously 4, 5
Special Populations Requiring Dose Adjustment
Renal Impairment - As Needed Dosing
- CrCl 30-50 mL/min: Start with 5 mg, maximum 10 mg once every 48 hours 1
- CrCl <30 mL/min or hemodialysis: Maximum 5 mg once every 72 hours 1
Renal Impairment - Daily Dosing
- CrCl 30-50 mL/min (for BPH or ED/BPH): Start with 2.5 mg, may increase to 5 mg based on response 1
- CrCl <30 mL/min or hemodialysis: Daily dosing NOT recommended for any indication 1
Hepatic Impairment - As Needed Dosing
- Mild to moderate (Child-Pugh A or B): Maximum 10 mg once per day 1
- Severe (Child-Pugh C): NOT recommended 1
Hepatic Impairment - Daily Dosing
The 2018 AUA guideline specifically notes that PDE5 inhibitors should be used cautiously at lower initial doses in men with mild to moderate hepatic or renal impairment, and are generally not recommended in severe disease 2
Critical Drug Interactions Affecting Dosing
Alpha-Blockers
When coadministering with alpha-blockers for ED, patients must be stable on alpha-blocker therapy first, and tadalafil should be initiated at the lowest recommended dose 1
Nitrates
Absolute contraindication - never use together due to severe hypotension risk 6, 1. The 2023 AHA/ACC Chronic Coronary Disease Guideline emphasizes:
- Avoid nitrates for ≥24 hours after sildenafil/vardenafil
- Avoid nitrates for ≥48 hours after tadalafil (due to 17.5-hour half-life) 6
Clinical Context from Guidelines
The 2018 AUA Erectile Dysfunction Guideline emphasizes that dose titration is essential - clinicians should work with patients to find the optimal dose balancing efficacy and side effects 2. Many treatment failures result from incorrect use (lack of sexual stimulation, taking with large meals), so proper patient education is critical 2.
For chronic prostatitis/chronic pelvic pain syndrome, the 2025 AUA guideline suggests daily tadalafil 5 mg may improve prostatitis symptoms, particularly in patients with concomitant ED 7.
Common pitfalls to avoid:
- Starting at maximum doses without titration opportunity
- Failing to adjust for renal/hepatic impairment
- Not screening for nitrate use before prescribing
- Inadequate patient counseling on proper use and timing